BMJ Clinical Evidence

• Effects of drug treatment in primary hypertension.

• Antihypertensive drug therapy for mild to moderate hypertension during pregnancy .
  
  
• Oral beta-blockers for mild to moderate hypertension during pregnancy .
  
  
• Pharmacotherapy for hypertension in the elderly.
  
  
• Pharmacotherapy for hypertension in women of different races.
  
  

• Betablockers for hypertension (Protocol).
  
• Blood pressure lowering efficacy of calcium channel blockers for primary hypertension (Protocol).
• Blood pressure lowering efficacy of loop diuretics for primary hypertension (Protocol).
• Blood pressure lowering efficacy of thiazide diuretics for primary hypertension (Protocol).
• Comparison of calcium channel blockers with other classes of drugs for hypertension (Protocol).
• Comparison of pharmacological interventions for hypertension (Protocol).
• Dose-related blood pressure lowering efficacy of angiotensin converting enzyme inhibitors in the treatment of primary hypertension (Protocol).
• Dose-related blood pressure lowering efficacy of angiotensin receptor blockers in the treatment of primary hypertension (Protocol).
• Methyldopa in the management of essential hypertension (Protocol).
• Pharmacological interventions for hypertension (Protocol).
• Pharmacotherapy for hypertension in people of sub-Saharan Africa or of sub-Saharan African descent (Protocol).
• Reserpine for hypertension (Protocol).
• Treatment of hypertension in peripheral arterial disease (Protocol).

• Angiotensin II antagonists for hypertension: are there differences in efficacy.
  structured abstract of: Colin P R, Spence J D, Williams B, Ribeirao A B, Saito I, Benedict C, Bunt A M. Angiotensin II antagonists for hypertension: are there differences in efficacy. American Journal of Hypertension. 2000. 13(4 Part 1). 418-426.
  
  
• Are B-blockers efficacious as first-line therapy for hypertension in the elderly: a systematic review.
  structured abstract of: Messerli F H, Grossman E, Goldbourt U. Are B-blockers efficacious as first-line therapy for hypertension in the elderly: a systematic review. JAMA. 1998. 279(23). 1903-1907.
  
  
• A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides.
  structured abstract of: Ames R P. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. American Journal of Cardiology. 1996. 77(6). 12B-16B.
  
  
• Does drug treatment improve survival: reconciling the trials in mild-to-moderate hypertension.
  structured abstract of: Hoes A W, Grobbee D E, Lubsen J. Does drug treatment improve survival: reconciling the trials in mild-to-moderate hypertension. Journal of Hypertension. 1995. 13(7). 805-811.
  
  
• Drug treatment of hypertension in the elderly: a meta-analysis.
  structured abstract of: Insua J T, Sacks H S, Lau, T S et al. Drug treatment of hypertension in the elderly: a meta-analysis. Annals of Internal Medicine. 1994. 121(5). 355-362.
  
  
• Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation.
  structured abstract of: Hilleman D E, Ryschon K L, Mohiuddin S M, Wurdeman R L. Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation. Journal of Human Hypertension. 1999. 13(7). 477-483.
  
  
• High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal.
  structured abstract of: Grossman E, Messerli F H, Goldbourt U. High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal. Archives of Internal Medicine. 2000. 160. 2447-2452.
  
  
• Hypertension in the elderly: implications and generalizability of randomized trials.
  structured abstract of: Mulrow C D, Cornell J A, Herrera C R, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: implications and generalizability of randomized trials. JAMA. 1994. 272(24). 1932-1938.
  
  
• Hypertension in the elderly: pressure to treat?.
  structured abstract of: Sanderson S. Hypertension in the elderly: pressure to treat?. Health Trends. 1996. 28(4). 117-121.
  
  
• Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension.
  structured abstract of: Malik A S, Warshafsky S, Lehrman S. Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension. Archives of Internal Medicine. 1997. 157. 621-625.
  
  
• Nebivolol in the management of essential hypertension: a review.
  structured abstract of: McNeely W, Goa K L. Nebivolol in the management of essential hypertension: a review. Drugs. 1999. 57(4). 633-651.
  
  
• New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
  structured abstract of: Gueyffier F, Froment A, Gouton M. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. Journal of Human Hypertension. 1996. 10(1). 1-8.
  
  
• Safety of nifedipine in patients with hypertension: a meta-analysis.
  structured abstract of: Stason WB, Schmid CH, Niedzwiecki D, Whiting GW, Caubet J-F, Luo D, Ross SD, Chalmers TC. Safety of nifedipine in patients with hypertension: a meta-analysis. Hypertension. 1997. 30(1 Part 1). 7-14.
  
  
• Treatment of high blood pressure in patients aged over 60 years: lessons from randomized clinical trials.
  structured abstract of: Lievre M, Leizorovicz A. Treatment of high blood pressure in patients aged over 60 years: lessons from randomized clinical trials. Cardiology in the Elderly. 1995. 3(3). 217-222.
  
  

• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. 1997 (revised 2003 May 21).
• Diagnosis and management of hypertension in the primary care setting. [U.S.] Department of Veterans Affairs - Federal Government Agency [U.S.] Veterans Health Administration - Federal Government Agency [U.S.]. 1999 May.
• Hypertension. National Committee on Cardiac Care (Singapore) - National Government Agency [Non-U.S.] National Medical Research Council (Singapore Ministry of Health) - National Government Agency [Non-U.S.] Singapore Cardiac Society - Medical Specialty Society Singapore Ministry of Health - National Government Agency [Non-U.S.]. 2000 Dec.
• Essential Hypertension. University of Michigan Health System - Academic Institution. 1997 (revised 2002 Aug).
• Hypertension diagnosis and treatment. Institute for Clinical Systems Improvement - Private Nonprofit Organization. 1995 Jun (revised 2002 Jan).
  
• list of all results (64) = hypertension and combination